On this page
What each program costs in Maryland
The monthly price is all-in: the drug plus a membership when we have verified one. Compounded drugs are not FDA-approved.
| # | Program | Cheapest product | Plan | All in | Membership fee | Trustpilot | Checked | Seller site |
|---|---|---|---|---|---|---|---|---|
| 1 | Compounded Semaglutide | sale price | $39/mo | not verified | too few reviews | Visit | ||
| 2 | Compounded Semaglutide | 12-month plan, $588 up front | $49/mo | none | 3.9 (11,798 reviews) | Visit | ||
| 3 | Compounded Semaglutide | month to month | $59/mo | none | too few reviews | Visit | ||
| 4 | Compounded Semaglutide | 12-month plan, $828 up front | $69/mo | none | 4.6 (4,268 reviews) | Visit | ||
| 5 | Compounded Semaglutide | medication monthly, membership yearly | $75/mo | $199/yr, included | 4.8 (288 reviews) | Visit | ||
| 6 | Compounded Semaglutide | month to month | $79/mo | none | too few reviews | Visit | ||
| 7 | Compounded Semaglutide | month to month | $99/mo | none | 4.6 (5,235 reviews) | Visit | ||
| 8 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.3 (880 reviews) | Visit | ||
| 9 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.2 (218 reviews) | Visit | ||
| 10 | Compounded Semaglutide | 12-month plan, $1,260 up front | $105/mo | none | too few reviews | Visit | ||
| 11 | Compounded Semaglutide | 12-month plan, $1,698 up front | $141/mo | none | too few reviews | Visit | ||
| 12 | Semaglutide | month to month | $149/mo | none | too few reviews | Visit | ||
| 13 | Compounded Semaglutide | 12-month plan, $1,788 up front | $149/mo | none | 4.2 (777 reviews) | Visit | ||
| 14 | Microdosing Tirzepatide | 12-month plan, $2,028 up front | $169/mo | none | 4.0 (162 reviews) | Visit | ||
| 15 | Compounded Semaglutide | 2-month plan, $350 up front | $175/mo | none | 4.6 (1,084 reviews) | Visit | ||
| 16 | Compounded Oral Semaglutide Capsules | 6-month plan, $1,194 up front | $199/mo | none | too few reviews | Visit | ||
| 17 | Foundayo (brand orforglipron) | medication monthly, membership yearly | $208/mo | $59/mo, billed yearly, included | 4.6 (4,607 reviews) | Visit | ||
| 18 | Sublingual Semaglutide | month to month | $249/mo | none | 4.5 (17,622 reviews) | Visit | ||
| 19 | Compounded Semaglutide | month to month | $299/mo | none | too few reviews | Visit |
Does Maryland Medicaid cover GLP-1s for weight loss?
Not covered for weight loss
Maryland Medicaid does not cover Wegovy when weight management is the only reason, and its prior authorization form limits Zepbound to moderate to severe sleep apnea with obesity. Read from state documents Nov 6, 2026.
What Maryland Medicaid's documents say about each drug for weight loss. Read Nov 6, 2026. Maryland Department of Health, Office of Pharmacy Services.
WegovyNo
Prior authorization for established heart disease with overweight or obesity (BMI 27 or higher), or for a liver condition (MASH) with moderate to advanced fibrosis.
“Wegovy will not be covered when the sole indication is for chronic weight management”
Maryland Department of Health, Medical Benefits Management · Effective Sep 15, 2024 · read Nov 6, 2026
“The Medical Assistance Program covers Byetta, Ozempic, Trulicity, Victoza, Bydureon, Mounjaro, Rybelsus, and Wegovy for FDA-approved indications other than obesity.”
Maryland Department of Health · No effective date on the document · read Nov 6, 2026
“Patient has non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH)”
Maryland Department of Health, Office of Pharmacy Services · No effective date on the document · read Nov 6, 2026
ZepboundNo
Prior authorization for moderate to severe sleep apnea with obesity (BMI 30 or higher), with a sleep specialist, pulmonologist or other experienced provider.
“Patient has moderate to severe obstructive sleep apnea (OSA) diagnosed by polysomnography or home sleep study”
Maryland Department of Health, Office of Pharmacy Services · No effective date on the document · read Nov 6, 2026
OzempicNo
Covered for type 2 diabetes. On the preferred drug list updated August 6, 2026.
“The Medical Assistance Program covers Byetta, Ozempic, Trulicity, Victoza, Bydureon, Mounjaro, Rybelsus, and Wegovy for FDA-approved indications other than obesity.”
Maryland Department of Health · No effective date on the document · read Nov 6, 2026
MounjaroNo
Covered for type 2 diabetes. On the preferred drug list updated August 6, 2026.
“The Medical Assistance Program covers Byetta, Ozempic, Trulicity, Victoza, Bydureon, Mounjaro, Rybelsus, and Wegovy for FDA-approved indications other than obesity.”
Maryland Department of Health · No effective date on the document · read Nov 6, 2026
This reports what the documents say. It is not medical or legal advice: your plan and your prescriber decide.
What changed, and when
- Nov 6, 2026 · This pageFirst read from Maryland Department of Health, Office of Pharmacy Services documents. KFF's January 2026 map listed this program as not covered; the documents we read agree.
Weight loss
Not covered, read Nov 2026
Type 2 diabetes
Required in every state
Heart risk, sleep apnea
Required (Wegovy, Zepbound)
Prior authorization
Typical when covered
Wegovy, Zepbound, Saxenda, 2025
3,049 prescriptions
Ozempic and Mounjaro, 2025
119,712 prescriptions
Neighbours covering weight loss
1 of 5
Federal law lets each state decide whether Medicaid pays for drugs used for weight loss, while drugs approved for diabetes must be covered. A state document may not settle every plan; if your Maryland Medicaid coverage comes through a managed care plan, its formulary can differ, so ask the plan before you fill.
For comparison, a dated secondary source: KFF's January 2026 map listed Maryland Medicaid as "not covered" for GLP-1s for obesity under fee-for-service.
The BALANCE model
CMS’s BALANCE model lets state Medicaid programs add GLP-1s for weight management at a negotiated price. States could join on a rolling basis from May 1, 2026 through January 1, 2027, and the state application deadline was July 31, 2026. We could not find a published list of the states that joined, so this page does not say whether Maryland Medicaid did. Ask your plan. Either way your cost stays at Medicaid’s nominal copay, which BALANCE does not change.
The national picture, coupons and patient assistance: does Medicaid cover GLP-1s.
How many GLP-1s does Maryland Medicaid pay for?
148,487 GLP-1 prescriptions in 2025, 19th of the 50 states and DC, with $141.6 million reimbursed before rebates. Counting the share other payers covered, $142.7 million.
Prescriptions, 2025
148,487
19th of 51
Medicaid paid
$141.6M
20th of 51, before rebates
Per prescription
$953
$1,051 nationally
Weight-loss brands
2.1%
32nd highest share of 51
CMS State Drug Utilization Data 2025, updated Jul 13, 2026, fee-for-service and managed care, before rebates. Maryland is highlighted. CMS publishes this comparison as one year, not a trend.
Wegovy, Zepbound and Saxenda, the brands approved for weight management, were 2.1% of Maryland Medicaid's GLP-1 prescriptions in 2025 (3,049). Across the 13 states KFF lists as covering GLP-1s for obesity, the median share was 52%; across the other 38, 2.3%. Where weight loss is not covered, those brands are mostly filled for the uses Medicaid must cover, such as heart risk and sleep apnea. Ozempic was Maryland Medicaid's most filled GLP-1.
| Brand | Prescriptions | Share | Medicaid paid | Per Rx |
|---|---|---|---|---|
| Ozempic | 101,266 | 68% | $96.6 million | $954 |
| Mounjaro | 18,446 | 12% | $19.3 million | $1,047 |
| Trulicity | 15,588 | 10% | $14.2 million | $912 |
| Rybelsus | 7,465 | 5.0% | $7.1 million | $954 |
| Liraglutide (generic) | 2,634 | 1.8% | $807,409 | $307 |
| Zepboundapproved for weight management | 1,909 | 1.3% | $2.0 million | $1,031 |
| Wegovyapproved for weight management | 1,140 | 0.8% | $1.5 million | $1,275 |
| Bydureon | 39 | 0.0% | $31,663 | $812 |
Source: CMS State Drug Utilization Data 2025, updated Jul 13, 2026, all four quarters, fee-for-service and managed care. Before rebates. CMS suppresses rows under 11 prescriptions, so small brands are undercounted slightly. Every state ranked: prescriptions and spending.
Which FDA-registered outsourcing facilities are in Maryland?
FDA's register of 503B outsourcing facilities, updated Nov 17, 2026, lists 1 in Maryland. The register does not say which, if any, supplies a program on this page.
- GFC Pharma, LLC, Westminster. Registered since Dec 16, 2024; not yet inspected by FDA.
On Medicare in Maryland?
Medicare’s temporary GLP-1 Bridge works the same in every state: a $50 copay for a one-month supply of Wegovy, Foundayo or the Zepbound KwikPen, for people with Part D who meet its weight and health rules.
medicare.gov
“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”
https://www.medicare.gov/coverage/weight-loss-drugs · read Nov 14, 2026
Maryland and the states around it
Medicaid’s weight-loss answer (the state’s own documents where we have read them, otherwise KFF, January 2026) and the partner programs that ship there, priced the same way as above.
1 of the 5 states next to Maryland covers GLP-1s for weight loss through Medicaid: Virginia. None has a lower cash floor than Maryland's $39.
| State | Medicaid, weight loss | Ship there | Cheapest that ships there |
|---|---|---|---|
| Maryland | Not covered | 19 | $39/mo |
| Delaware | Documents conflict | 19 | $39/moWellmedr |
| Pennsylvania | Not covered | 19 | $39/moWellmedr |
| Virginia | Covered | 19 | $39/moWellmedr |
| West Virginia | Not covered | 18 | $39/moWellmedr |
| Washington, DC | Not covered | 0 | none verified |






















